Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Elevance Health

Elevance Health Stock Outlook: Is Wall Street Bullish or Bearish?

Elevance Health has underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.

Barchart

Stock Index Futures Plunge With Tech Under Pressure, U.S. Economic Data and Earnings in Focus

September S&P 500 E-Mini futures (ESU24) are down -0.79%, and September Nasdaq 100 E-Mini futures (NQU24) are down -1.22% this morning as concerns over stricter U.S. restrictions on Chinese trade and semiconductor technology weighed on sentiment, while investors awaited a fresh batch of U.S. economic data and the next round…

Barchart

Elevance Health’s Q2 2024 Earnings: What to Expect

Elevance Health is expected to release its second-quarter earnings later this month, and analysts project a double-digit earnings growth.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Elevance Health a Top Healthcare Stock to Buy Now?

Elevance Health’s (ELV) diverse product portfolio, leading market position, strategic initiatives, and technological investments contribute to its promising growth prospects. So, let’s find out if ELV is an ideal choice for investors interested in the healthcare industry. Read more….

StockNews.com

Is Elevance Health Stock Outperforming the S&P 500?

Elevance Health has outperformed the S&P 500 this year, and analysts remain optimistic about the stock's prospects due to its strong market presence and robust financial performance.

Barchart

Stocks Finish Lower on Hawkish Fed and Rising Bond Yields

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.57%. US stock indexes gave up early gains on Thursday and settled mixed, with the...

Barchart

Stocks Give Up Early Gains and are Now in the Red

The S&P 500 Index ($SPX ) (SPY ) is down -0.24%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.42%. US stock indexes are moderately lower. Earlier this morning, better-than-expected US economic reports showed economic...

Barchart

Read news from The Economist, FT, and more,
with one subscription

Solid US Economic News and Strong Earnings Boost Stocks

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.31%. US stock indexes this morning are moderately higher. Stocks are finding support on...

Barchart

Stocks Rise Before the Open With Earnings in Focus, U.S. Economic Data and Fed Speak on Tap

June S&P 500 E-Mini futures (ESM24) are up +0.12%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.27% this morning as investors awaited a new round of U.S. economic data, comments from Federal Reserve officials, as well as corporate earnings reports, with the spotlight on results from streaming giant…

Barchart

3 Safe Haven Stocks to Own in an Unpredictable Market

Even though 2024 kicked off strong, recent macroeconomic uncertainties highlight the need for resilient investments. These three “safe haven” stocks are worth considering for hedging against the market downswings.

Barchart

Clover Health (CLOV) vs. Elevance Health (ELV): Buy, Hold, or Sell in 2024

The medical sector’s prospects look attractive with increasing global demand for quality healthcare services and technological advances in healthcare systems. So, let’s analyze the fundamentals of medical stocks Clover Health Investments (CLOV) and Elevance Health (ELV).

StockNews.com

These Companies Just Breached Their 200-Day SMA and Turned Bullish!

This article considers 3 companies that have recently crossed above their 200-Day SMA.

Barchart

The Newest Member Of The Medical Team: AI

Leaders in medical innovation debate how artificial intelligence is changing healthcare and why this is advantageous for patients.

Zenger

3 Top Stocks to Buy During a Recession

Although the Fed might opt for a softer stance on the rate hike at the policy meeting this week, the fears of further aggressive rate hikes later this year remain. This, along with the banking crisis, is fueling recession concerns. Therefore, investing in defensive stocks McDonald’s (MCD), Elevance Health (ELV),…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Stocks to Buy With Rising Recession and Rate Risk

The stock market continues to be a challenging environment with rising rates a potent headwind. So far, the economy has been stable enough so that earnings growth has not contracted, but this is unlikely to persist the longer the Fed stays hawkish. This article discusses characteristics of stocks that are…

StockNews.com

2 Defensive Stocks to Consider With Market Conditions Turning More Bearish

The stock market has given back the bulk of its gains following a stronger than expected inflation print. Amid these challenging circumstances, investors should consider high-quality, defensive stocks like Elevance Health (ELV) and Northrop Grumman (NOC).

Benzinga

Why Analysts Love This High Yield Health Care Stock, Which Just Changed Its Name

Elevance Health Inc (NYSE: ELV) (previously known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

Upgrades

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This Is What Whales Are Betting On Elevance Health

Someone with a lot of money to spend has taken a bullish stance on Elevance Health (NYSE:ELV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022

Upgrades

StockNews.com

3 Stocks to Buy With Rising Recession Risk, Increasing Geopolitical Tensions

Despite the bear market rally, the market is facing serious risks due to rising recession risk and increasing geopolitical tensions. Here are 3 defensive picks to help investors outperform in this tricky environment: Lockheed Martin (LMT), Vertex Pharmaceuticals (VRTX), and Elevance Health (ELVH).

Benzinga

Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 10 Years

Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 12.12% on an annualized basis producing an average annual return of 22.8%. Currently, Elevance Health has a market capitalization of $115.15 billion.

1 2 3

People

Joe Biden

69,065 stories

Mangeet Kaur BounsMangeet

Jaimini DesaiJaimini Desai

59 stories

Loretta Mester

52 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.